Adagio Medical Holdings, Inc.(ADGM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADGM Adagio Medical Holdings, Inc.

Trading 12-08 12:14:03 EST

0.9107

-0.0153

-1.65%

High0.9640	Low0.9000	Vol14.18K
Open0.9231	D1 Closing0.9260	Amplitude6.91%
Mkt Cap19.29M	Tradable Cap2.08M	Total Shares21.18M
T/O13.05K	T/O Rate0.62%	Tradable Shares2.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADGM","market":"US","secType":"STK","nameCN":"Adagio Medical Holdings, Inc.","latestPrice":0.9107,"timestamp":1765213869192,"preClose":0.926,"halted":0,"volume":14178,"delay":0,"floatShares":2285400,"shares":21179637,"eps":-5.155606,"marketStatus":"Trading","change":-0.0153,"latestTime":"12-08 12:14:03 EST","open":0.9231,"high":0.964,"low":0.9,"amount":13051.8116862,"amplitude":0.069114,"askPrice":0.96,"askSize":100,"bidPrice":0.8506,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.155606,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765227600000},"marketStatusCode":2,"adr":0,"listingDate":1614315600000,"exchange":"NASDAQ","adjPreClose":0.926,"preHourTrading":{"tag":"盘前","latestPrice":0.92,"preClose":0.926,"latestTime":"09:26 EST","volume":67,"amount":61.64,"timestamp":1765203984027},"postHourTrading":{"tag":"盘后","latestPrice":0.926,"preClose":0.926,"latestTime":"19:52 EST","volume":31,"amount":29.1585,"timestamp":1764982325534},"volumeRatio":0.239868},"requestUrl":"/m/hq/s/ADGM/wiki","defaultTab":"wiki","newsList":[{"id":"2588054564","title":"Adagio Medical Initiated at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2588054564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588054564?lang=en_us&edition=fundamental","pubTime":"2025-12-02 23:04","pubTimestamp":1764687840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADGM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 10:04 ET (15:04 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2588742444","title":"Abu Dhabi Government Developer Modon Makes Its Official Taiwan Debut Announces Market Entry and Launches Flagship ADGM Project \"Muheira II\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2588742444","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588742444?lang=en_us&edition=fundamental","pubTime":"2025-12-01 15:57","pubTimestamp":1764575820,"startTime":"0","endTime":"0","summary":"TAIPEI, Dec. 1, 2025 /PRNewswire/ --Abu Dhabi's government-backed developer Modon announced its official entry into the Taiwan market today at a press conference held at eslite hotel Taipei, unveiling the flagship residential project Muheira II, located in the core area of the Abu Dhabi Global Market  financial district. This marks Modon's first expansion into the Asia-Pacific region, signaling the arrival of Middle Eastern real estate capital in Taiwan and offering local investors a high-growth opportunity backed by a government-owned developer.Abu Dhabi Master Developer Modon Enters the Taiwan Market，Modon Chief Commercial Officer, Mohammed Abdelrazik , and Knightsbridge Partners CEO, Kelvin , personally attended the press conference.","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2834940/Abu_Dhabi_Master_Developer_Modon_Enters_Taiwan_Market_Modon_Chief_Commercial.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2834940/Abu_Dhabi_Master_Developer_Modon_Enters_Taiwan_Market_Modon_Chief_Commercial.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/abu-dhabi-government-developer-modon-makes-its-official-taiwan-debut-announces-market-entry-and-launches-flagship-adgm-project-muheira-ii-302628936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2584180693","title":"Mondevo Group Unveils ITTIKAR: The World's First AI-Native Merchant Bank for Family Offices","url":"https://stock-news.laohu8.com/highlight/detail?id=2584180693","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584180693?lang=en_us&edition=fundamental","pubTime":"2025-11-20 18:09","pubTimestamp":1763633340,"startTime":"0","endTime":"0","summary":"Launching in Q1, 2026, the platform will introduce dedicated AI agents for every family office, redefining access to the $6 trillion family office market.ABU DHABI, UAE, Nov. 20, 2025 /PRNewswire/ -- Mondevo Group today announces ITTIKAR, the world's first AI-native merchant bank built exclusively for family offices, with headquarters in Abu Dhabi Global Market .Following 12 months of intensive development by MonTech's team of more than 40 AI engineers in Singapore, ITTIKAR will officially launch in Q1 2026, fundamentally transforming how family offices access private markets and deploy capital.ITTIKAR's competitive differentiation lies in its fundamental architectural philosophy. Traditional AI-powered platforms in financial services deploy product-centric models with AI algorithms designed to match products to customers at scale. ITTIKAR inverts this paradigm entirely by deploying one dedicated AI agent per family office, creating a service-oriented approach that prioritises each fam","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2828505/ITTIKAR_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2828505/ITTIKAR_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/mondevo-group-unveils-ittikar-the-worlds-first-ai-native-merchant-bank-for-family-offices-302621576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AI","BK6512","BK4587","BK4543","BK4588","BK4082","BK6052","BK4023","ADGM","BK4551","BK6025","5SY.SI","BK4585","BK4528"],"gpt_icon":0},{"id":"2583958531","title":"Adagio Medical Holdings Q3 EPS $(0.66) Down From $0.02 YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2583958531","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583958531?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:37","pubTimestamp":1762983467,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.66) per share. This is a 3400 percent decrease over earnings of $0.02 per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48820441/adagio-medical-holdings-q3-eps-0-66-down-from-0-02-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","MNQmain","USJW.SI","NVIW.SI","PSQ","TSYW.SI","QLD","USAW.SI","TQQQ","QID","ADGM","NQmain","BK4082",".IXIC"],"gpt_icon":0},{"id":"2583588696","title":"Adagio Medical Holdings posts Q3 net loss of $10.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583588696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583588696?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:08","pubTimestamp":1762981722,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings Inc. reported a net loss of $10.1 million for the third quarter ended September 30, 2025, compared to a net loss of $4.6 million for the same period in 2024. Cost of revenue was $0.03 million, down from $0.6 million in the prior-year quarter. Research and development expenses rose to $2.8 million from $2.5 million, while selling, general and administrative expenses decreased to $2.9 million from $7.8 million. The company reported cash and cash equivalents of $4.7 million as of September 30, 2025. Recent business developments include the completion of a private placement with gross proceeds of up to $50 million, the completion of enrollment in the 209-patient FULCRUM-VT pivotal trial, and the appointment of Deborah Kaster as Chief Financial Officer in addition to her role as Chief Business Officer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL60fSlh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XTNT","BK4198","ADGM"],"gpt_icon":0},{"id":"2583588373","title":"Press Release: Adagio Medical Reports Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583588373","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583588373?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:05","pubTimestamp":1762981500,"startTime":"0","endTime":"0","summary":"Continued Momentum Toward PMA Submission of ULTC Technologies. Recent Financing Positions Company to Execute Growth Strategy. Adagio Medical Holdings, Inc  , a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the third quarter ended September 30, 2025.--  Closed a private placement on October 20, 2025, with gross proceeds of. institutional investors; upfront proceeds of approximately $19 million. catheter development, with potential for up to $31 million in additional. Investigational Device Exemption  trial intended to support the. 97% acute effectiveness and a favorable safety profile with the Company's. Kaster as Chief Financial Officer, adding to her role as Chief Business. Reported cash and cash equivalents of $4.7 million as of September 30, 2025.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4082","BK4555","BK4604","ADGM","TM","BK4585","BK4588","03160"],"gpt_icon":0},{"id":"2582237733","title":"Mondevo Group Establishes Global Headquarters in Abu Dhabi Global Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2582237733","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582237733?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:18","pubTimestamp":1762957080,"startTime":"0","endTime":"0","summary":"Mondevo Group selected ADGM for its innovation-friendly regulation, advanced AI infrastructure, and global connectivity. Abu Dhabi's leadership in digital transformation and commitment to technological development and adoption provide an ideal foundation for Mondevo's long-term vision.","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2821246/Abu_Dhabi_Global_Market.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2821246/Abu_Dhabi_Global_Market.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/mondevo-group-establishes-global-headquarters-in-abu-dhabi-global-market-302613150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","STRK","AI","BK4023","BK4587","BK4595","BK4585","BK4543","BK4082","BK4588","BK4596","BK4600","ADGM","BK4516","BK4528"],"gpt_icon":1},{"id":"2581727295","title":"Adagio Medical Holdings Inc. to Present at Piper Sandler 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2581727295","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581727295?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:00","pubTimestamp":1762347642,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings Inc., a leader in catheter ablation technologies for cardiac arrhythmias, will present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 10:30 a.m. ET in New York, NY.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagio Medical Holdings Inc. published the original content used to generate this news brief via Business Wire  on November 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL4RbwX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BK4082","PIPR","XTNT","ADGM","BK4198"],"gpt_icon":0},{"id":"2580139952","title":"AlphaTON Capital Takes Center Stage at TRUST Summit 2025 to Shape the Future of Digital Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2580139952","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580139952?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:00","pubTimestamp":1762174800,"startTime":"0","endTime":"0","summary":"AlphaTON Capital joins forces with cybersecurity leader Hacken at Nasdaq to advance institutional trust and redefine the future of digital asset securityNew York, NY, Nov.  03, 2025  (GLOBE NEWSWIRE) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179213/0/en/AlphaTON-Capital-Takes-Center-Stage-at-TRUST-Summit-2025-to-Shape-the-Future-of-Digital-Finance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATON","SQQQ","SMMF","BK4139","ADGM","NQmain","PSQ","NVIW.SI","MNQmain",".IXIC","USAW.SI","USJW.SI","QLD","SSI","TQQQ","QID","BK4211","BK4082","TSYW.SI"],"gpt_icon":1},{"id":"2577837377","title":"Modon Appoints Knightsbridge Partners as Exclusive Asia-Pacific Region Master Agent for Muheira Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2577837377","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577837377?lang=en_us&edition=fundamental","pubTime":"2025-10-23 15:00","pubTimestamp":1761202800,"startTime":"0","endTime":"0","summary":"HONG KONG, Oct. 23, 2025 /PRNewswire/ -- Modon, an international holding company headquartered in Abu Dhabi, has commissioned Knightsbridge Partners to serve as the exclusive Asia-Pacific region master agent for its Muheira Phase 2 project, coordinating sales and marketing activities throughout the region.Phase 1 of Muheira, an exclusive residential development located within walking distance of Abu Dhabi Global Market , sold out on the day of launch in May. Knightsbridge Partners' mandate for Phase 2 will include managing the Asia-Pacific regional agency network, overseeing brand compliance, supervising the marketing budget, and executing events in select markets. Knightsbridge Partners will also coordinate with a selected network of sub-agents, ensuring that all efforts align with Modon's launch strategy and standards.Located close to ADGM – Abu Dhabi's international financial centre – Muheira represents one of the emirate's key residential offerings, blending luxury living with stro","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2802339/Muheira_II_Exclusive_Launch_Asia.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2802339/Muheira_II_Exclusive_Launch_Asia.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/modon-appoints-knightsbridge-partners-as-exclusive-asia-pacific-region-master-agent-for-muheira-phase-2-302591265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADX","BK7142","BK4082","ADGM","ADX.AU"],"gpt_icon":0},{"id":"2576859987","title":"Adagio Medical Raises $19 Million in Private Placement to Advance VT Treatment Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859987","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859987?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:01","pubTimestamp":1760961686,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings Inc. has closed a $19 million private placement, led by existing and new healthcare-dedicated institutional investors. The company, a leader in catheter ablation technologies for cardiac arrhythmias, plans to use the proceeds to support submission activities for its FULCRUM-VT pivotal clinical study for premarket approval of the vCLAS ULTC System by the U.S. FDA. Additional funds will advance clinical experience and FDA submission for its next-generation ULTC catheter, build awareness of the technology, expand manufacturing, and strengthen corporate operations. The financing is expected to extend the company's cash runway and support key milestones.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagio Medical H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDLC3tTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ADGM","BK4198","XTNT"],"gpt_icon":0},{"id":"2576859577","title":"Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859577?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:01","pubTimestamp":1760961665,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3VZ0F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2575784722","title":"Adagio Medical Holdings Inc - Enters Securities Purchase Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575784722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575784722?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:24","pubTimestamp":1760531061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nFWN3VW1VO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2575281781","title":"Adagio Medical Holdings Inc. Announces $50 Million Private Placement Led by Perceptive Advisors, Raising $19 Million Upfront with Potential for Additional $31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2575281781","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575281781?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:00","pubTimestamp":1760529657,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings Inc. Announces $50 Million Private Placement Led by Perceptive Advisors, Raising $19 Million Upfront with Potential for Additional $31 Million. Adagio Medical Holdings Inc. has announced a private placement of securities expected to generate approximately $19 million in upfront proceeds, with the potential for up to an additional $31 million if accompanying warrants are fully exercised for cash. The financing is led by an affiliate of existing investor Perceptive Advisors, LLC, alongside participation from other healthcare-focused and institutional investors. The company plans to use the net proceeds for working capital and general corporate purposes, including advancing clinical and product development activities. Piper Sandler is acting as the sole placement agent, and Lake Street is serving as financial advisor for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nNDL7tXY35:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PIPR","ADGM","XTNT","BK4127","BK4198"],"gpt_icon":0},{"id":"2575878143","title":"Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2575878143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575878143?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:00","pubTimestamp":1760529602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUA9TDNKK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2574110244","title":"Adagio Medical announces preliminary acute results from FULCRUM-VT study","url":"https://stock-news.laohu8.com/highlight/detail?id=2574110244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574110244?lang=en_us&edition=fundamental","pubTime":"2025-10-11 03:45","pubTimestamp":1760125516,"startTime":"0","endTime":"0","summary":"Adagio Medical (ADGM) announced preliminary acute safety and efficacy results from Adagio’s FULCRUM-VT Study evaluating Ultralow Temperature Cryoab...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adagio-medical-announces-preliminary-acute-results-from-fulcrum-vt-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adagio-medical-announces-preliminary-acute-results-from-fulcrum-vt-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4082","VT","ADGM"],"gpt_icon":0},{"id":"2574410400","title":"Adagio Medical Announces Preliminary Study Results Showing 97 Percent Acute Effectiveness for ULTC in Ventricular Tachycardia","url":"https://stock-news.laohu8.com/highlight/detail?id=2574410400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574410400?lang=en_us&edition=fundamental","pubTime":"2025-10-11 03:40","pubTimestamp":1760125214,"startTime":"0","endTime":"0","summary":"Adagio Medical Announces Preliminary Study Results Showing 97 Percent Acute Effectiveness for ULTC in Ventricular Tachycardia. Adagio Medical Holdings Inc. has announced preliminary acute safety and efficacy results from its FULCRUM-VT U.S. Pivotal Study, evaluating the company's Ultralow Temperature Cryoablation  system for the treatment of sustained monomorphic ventricular tachycardia  in patients with both ischemic and non-ischemic cardiomyopathy. The results, which are being presented at the 20th Annual International Symposium on Ventricular Arrhythmias in Philadelphia on October 10, 2025, show a 97.4% acute clinical success rate, defined as non-inducibility of target ventricular arrhythmias, and a 2.5% rate of major adverse events. The study included 207 patients across 19 sites in the United States and Canada.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDLkZ0rM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADGM","XTNT","BK4082","BK4198"],"gpt_icon":0},{"id":"2572320115","title":"Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572320115","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572320115?lang=en_us&edition=fundamental","pubTime":"2025-10-01 22:04","pubTimestamp":1759327458,"startTime":"0","endTime":"0","summary":"Oct 1 (Reuters) - Adagio Medical Holdings Inc ::*ADAGIO MEDICAL, INC. ANNOUNCES COMPLETION OF ENROLLMENT FOR FULCRUM-VT PIVOTAL CLINICAL TRIAL EVALUATING ULTRA-LOW TEMPERATURE CRYOABLATION FOR VENTRIC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nRSD8jRSgQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2572482536","title":"Adagio Medical Completes Enrollment in Pivotal U.S. Clinical Trial for Breakthrough Ultra-Low Temperature Cryoablation System for Ventricular Tachycardia","url":"https://stock-news.laohu8.com/highlight/detail?id=2572482536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572482536?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:01","pubTimestamp":1759320100,"startTime":"0","endTime":"0","summary":"Adagio Medical Completes Enrollment in Pivotal U.S. Clinical Trial for Breakthrough Ultra-Low Temperature Cryoablation System for Ventricular Tachycardia. Adagio Medical Holdings, Inc. has announced the completion of enrollment for the FULCRUM-VT pivotal clinical trial evaluating its vCLAS Cryoablation System for the treatment of monomorphic ventricular tachycardia . The U.S. Food and Drug Administration  has granted the vCLAS System Breakthrough Device Designation, and the device is currently available commercially for MMVT treatment in Europe and select other regions, while its use in the United States remains investigational. The company anticipates completion of the Premarket Approval  process for the vCLAS System by year-end 2026, consistent with previous guidance. Results from the FULCRUM-VT study have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL96b8yl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2572753697","title":"Adagio Medical, Inc. Announces Completion of Enrollment for Fulcrum-Vt Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia","url":"https://stock-news.laohu8.com/highlight/detail?id=2572753697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572753697?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:00","pubTimestamp":1759320005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA11BNP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ADGM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://adagiomedical.com","stockEarnings":[{"period":"1week","weight":0.1545},{"period":"1month","weight":-0.074},{"period":"3month","weight":-0.4139},{"period":"6month","weight":-0.2709},{"period":"1year","weight":-0.5884},{"period":"ytd","weight":-0.1181}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.03067},{"month":2,"riseRate":0.5,"avgChangeRate":-0.066888},{"month":3,"riseRate":0.2,"avgChangeRate":-0.015706},{"month":4,"riseRate":1,"avgChangeRate":0.134925},{"month":5,"riseRate":0.2,"avgChangeRate":-0.037196},{"month":6,"riseRate":1,"avgChangeRate":0.041251},{"month":7,"riseRate":0.6,"avgChangeRate":-0.088497},{"month":8,"riseRate":0.6,"avgChangeRate":-0.004955},{"month":9,"riseRate":0.8,"avgChangeRate":-0.052273},{"month":10,"riseRate":0.4,"avgChangeRate":-0.073772},{"month":11,"riseRate":0.6,"avgChangeRate":-0.057976},{"month":12,"riseRate":0.6,"avgChangeRate":-0.090776}],"exchange":"NASDAQ","name":"Adagio Medical Holdings, Inc.","nameEN":"Adagio Medical Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adagio Medical Holdings, Inc.(ADGM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adagio Medical Holdings, Inc.(ADGM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adagio Medical Holdings, Inc.,ADGM,Adagio Medical Holdings, Inc.股票,Adagio Medical Holdings, Inc.股票老虎,Adagio Medical Holdings, Inc.股票老虎国际,Adagio Medical Holdings, Inc.行情,Adagio Medical Holdings, Inc.股票行情,Adagio Medical Holdings, Inc.股价,Adagio Medical Holdings, Inc.股市,Adagio Medical Holdings, Inc.股票价格,Adagio Medical Holdings, Inc.股票交易,Adagio Medical Holdings, Inc.股票购买,Adagio Medical Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adagio Medical Holdings, Inc.(ADGM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adagio Medical Holdings, Inc.(ADGM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}